In Vitro and In Vivo Quality Evaluation of Glibenclamide Tablets Marketed in Addis Ababa, Ethiopia

Table 3

Time dependent drug release of different products of glibenclamide tablets.

sampling time (min)	Percent of drug release (W/W) ±RSD
	Betanase	Glitisol	Glamide	Melix	Daonil
10	52.77± 0.18	60.25±0.031	38.95±0.09	44.94±0.04	51.89±0.028
20	60.06±0.003	62.67±0.032	46.93±0.2	54.85±0.006	53.64±0.012
30	62.18 ±0.02	64.5±0.018	50.99±0.1	67.5 ±0.067	56.79± 0.06
45	64.65 ±0.28	67.358±0.01	54.57±0.07	70.13± 0.04	60.698±0.02
60	66.45± 0.01	70.34±0.019	58.88±0.08	73.16±0.035	61.57 ±0.072